Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2021 Feb 1.
Published in final edited form as: Osteoarthritis Cartilage. 2019 Oct 17;28(2):201–207. doi: 10.1016/j.joca.2019.10.003

Chondrocalcinosis is Associated with Increased Knee Joint Degeneration Over 4 Years: Data from the Osteoarthritis Initiative

Sarah C Foreman 1,2, Alexandra S Gersing 3, Claudio E von Schacky 4, Gabby B Joseph 5, Jan Neumann 6, Nancy E Lane 7, Charles E McCulloch 8, Michael C Nevitt 9, Thomas M Link 10
PMCID: PMC7002267  NIHMSID: NIHMS1543141  PMID: 31629813

Abstract

Objective

To determine if presence of calcium-containing crystals (CaC) is associated with increased knee joint degeneration over four years and assess if total number of CaCs deposited is a useful measure of disease burden.

Design

Seventy subjects with CaCs in right knees at baseline were selected from the Osteoarthritis Initiative and matched to 70 subjects without evidence of CaCs. T1-weighted gradient-echo sequences were used to confirm presence of CaCs and count the numbers of distinct circumscribed CaCs. Morphological abnormalities were assessed at baseline and four-year follow-up using the modified semi-quantitative Whole-Organ Magnetic Resonance Imaging Score (WORMS). Linear regression models were used to analyze the associations between presence of CaCs at baseline and changes in WORMS and to analyze the associations between numbers of circumscribed CaCs at baseline and changes in WORMS.

Results

Presence of CaCs was associated with increased cartilage degeneration in the patella (coefficient: 0.33; 95% confidence interval (CI): 0.04–0.63), the medial femur (coefficient: 0.51; 95% CI: 0.18–0.83), the lateral tibia (coefficient: 0.36; 95% CI: 0.01–0.71) as well as the medial and lateral meniscus (coefficient: 0.38; 95% CI: 0.00–0.75 and coefficient: 0.72; 95% CI: 0.121.32). Knees with higher numbers of CaCs had increased cartilage degeneration in the patella and medial femur (coefficient: 0.09; 95% CI: 0.05–0.14; p<0.001 and coefficient: 0.08; 95% CI: 0.020.14; p=0.005).

Conclusions

CaCs were associated with increased cartilage and meniscus degeneration over a period of four years. Assessing the number of CaC depositions may be useful to evaluate risk of onset and worsening of degenerative disease.

Keywords: osteoarthritis, MRI, knee, cartilage

Introduction

Chondrocalcinosis is an arthropathy defined as the presence of calcium-containing crystal (CaC) depositions on radiographs in cartilage or other soft-tissue structures of the joint [13]. The main two types of CaCs are basic calcium phosphate (BCP) and calcium pyrophosphate deposition (CPPD) crystals [1, 4, 5]. Since neither CT [6] nor MRI techniques are able to differentiate between these crystal types, we used the term CaCs to encompass both types in this study. CaCs have previously been described to be associated with symptomatic and asymptomatic radiographic knee osteoarthritis (OA), though CaCs and knee OA were both found to increase with age [7]. Currently, it remains unclear if CaCs are the cause or result from OA [8, 9].

Few MRI studies assessed the association of CaCs and structural knee joint degeneration. Recently a cross-sectional MRI study demonstrated that CaCs are associated with a higher prevalence of cartilage and meniscal damage [10]. A longitudinal knee MRI study evaluated synovitis at baseline and four-year follow-up in knees with and without CaCs but detected no statistically significant difference in change of synovitis between both groups [11]. Therefore, it would be of interest to determine how the presence of CaCs is associated with changes of other morphological knee joint structures using state of the art 3T MR imaging.

A previous CT study has shown that CaCs rarely occur as a solitary deposition but are typically ubiquitously present throughout the knee joint [6]. Yet to date it is unknown if these varying numbers of CaC depositions are related to disease onset or severity. Detecting circumscribed CaC depositions on MR imaging is challenging, however, a recent study has shown 3D gradient-echo MRI sequences to be useful for the visualization and quantification of circumscribed CaC depositions [10].

Therefore, the purpose of this study was firstly, to determine if presence of CaCs, confirmed by radiographs and MR sequences, is associated with increased structural knee joint degeneration over four years compared to controls without CaCs, and secondly, to assess if the total number of CaC depositions, assessed with 3D gradient echo MRI sequences, correlates with OA structural damage and could be used by clinicians to evaluate the disease burden.

Methods

Study subjects

We conducted a nested double cohort study selecting subjects based on presence or absence of CaCs at baseline from the Osteoarthritis Initiative (OAI; https://www.niams.nih.gov/grants-funding/funded-research/osteoarthritis-initiative); a longitudinal, multicenter study enrolling a total of 4796 participants with or at risk of developing knee OA. Kellgren-Lawrence (KL)-grades and presence of chondrocalcinosis, on radiographs were assessed by the central OAI radiograph readings. We used radiographs as the gold standard imaging modality for confirming presence of chondrocalcinosis. Radiographic chondrocalcinosis was defined as a definite linear cartilage calcification on the PA view in a compartment-specific manner as reported previously [9]. Moreover, we used 3D gradient-echo sequences to assess distinct circumscribed CaCs. Since these were only available in the right knee, we focused on the evaluation of the right knee of the participants in this study.

We selected subjects with no or mild radiographic OA in the right knee at baseline (KL-grade ≤2, n=3692), and excluded subjects with a history of inflammatory disorders (n=17) and no right knee MRI available at baseline or four-year follow-up (n=817). We excluded subjects with advanced or end-stage OA of the right knee (KL-grad 3 or 4), to avoid not being able to detect differences in changes between groups caused by score limitations for morphological changes at the top of the scale (ceiling effect). From the 2858 subjects who were eligible, we identified 70 subjects that showed radiographic chondrocalcinosis of the right knee at baseline based on central readings and confirmed by our review of radiographs. Moreover, we evaluated the appearance of CaCs on MRI as described previously, defined as presence of punctate foci of hypointensity on gradient-echo sequences along the cartilage or menisci [10]. We confirmed the presence of multiple hypointense foci on gradient-echo MRI sequences in all 70 subjects with radiographic chondrocalcinosis. For comparison, we selected 70 subjects without evidence of CaCs in the right or left knee, based on the central readings and confirmed by our review of radiographs. We then reviewed gradient-echo MRI sequences in all subjects without radiographic chondrocalcinosis and confirmed the absence of punctate foci of hypointensity in all subjects. To protect against confounding, we assessed the distribution of age, race, KL-grades and BMI in the CaC cohort and compared it to the distribution in the 2779 subjects who were eligible but did not have CaCs. Statistically significant differences were found for age, BMI and KL-grades, but not for sex and race. Therefore, the subjects in the comparison group were frequency matched to those with CaCs by randomly selecting 70 subjects from subgroups simultaneously defined by age (5-year intervals), BMI (2.5 kg/m2 intervals), and KL grade (0, 1, and 2), Fig 1. We also analyzed knee trauma in all subjects assessed by the question: “have you injured your right knee badly enough to limit your ability to walk for at least two days since the last visit?”.

Figure 1:

Figure 1:

Subject selection flowchart

MR imaging

MR images were acquired with 3T scanners (Siemens Magnetom Trio; Siemens, Erlangen, Germany) using standard transmit-receive knee coils (USA Instruments, Aurora, Ohio, USA). The following sequences from the MRI imaging protocol [12] were used: a 3D Tl-weighted fast low-angle shot (FLASH) gradient-echo sequence in a coronal plane (TlwGE) (20/7.6 /12°, TR/TE/flip angle) was used to count the numbers of distinct circumscribed CaCs [10]. Two 2D intermediate-weighted/proton density sequences in a sagittal plane (3200/30, TR/TE, with fat suppression) and coronal plane (3700/29, TR/TE) and a 3D dual-echo steady state (DESS) with water excitation (WE) sequence in a sagittal plane (16.3/4.7/25°, TR/TE/flip angle) were used to analyze morphological/structural abnormalities of the knee.

MR image analysis

MRIs were analyzed by two radiologists (S.C.F., A.S.G., 3 and 7 years of experience, respectively) in consensus and under supervision of a board-certified musculoskeletal radiologist (T.M.L., 25 years of experience). Images were analyzed in a randomized order and radiologists were blinded to clinical and radiographic findings.

CaC MRI gradings were performed at baseline. We evaluated MRI artifacts (e.g. motion and pulsation artefacts) on a scale from 5–1 (5, none; 4, mild, not affecting diagnostic value; 3, moderate, minor impact expected on diagnostic value; 2, pronounced, major impact on diagnostic value; 1, severe, no diagnostic value) [13] in all knees to assure sufficient image quality for the assessment of CaCs. All images were graded as ≥4, therefore no knees were excluded due to insufficient image quality. Presence or absence of CaCs was graded on T1wGE sequences and the numbers of distinct circumscribed CaCs were counted within the following cartilage regions as described previously [10]: patella (PAT), trochlea (TRO), medial femur (MF), lateral femur (LF), medial tibia (MT), lateral tibia (LT). One CaC lesion was defined as one distinct circumscribed hypointense focal area on 3D T1wGE sequences. Fig. 2 illustrates these lesions within hyaline cartilage.

Figure 2:

Figure 2:

Illustration of lesion count (white arrows) in the hyaline cartilage using T1-weighted gradient-echo sequences; (A) one lesion, (B) two lesions, (C) three lesions, (D) four lesions.

Morphological abnormalities were assessed at baseline and four-year follow-up using the modified semi-quantitative Whole-Organ Magnetic Resonance Imaging Score (WORMS) of the knee [14]. Cartilage lesions were scored on a scale from 0–6 in six subregions (PAT, TRO, MF, LF, MT, LT). Meniscal lesions were graded on IW- and PD-images together with T1wGE sequences to verify meniscal lesions were actual lesions and not mimicked by CaC depositions [10, 15]. Meniscal lesions were scored from 0–4 in each of the three subregions of the medial and lateral meniscus (anterior/body/posterior). BMEP and subchondral cysts were each scored from 0–3 in six subregions (PAT, TRO, MF, LF, MT, LT). Ligament abnormalities and effusion were graded as described previously [16, 17]. A sum score was calculated for each WORMS feature by adding the scores across all subregions of each knee [18].

Statistical analysis

The statistical analysis was performed with Stata software, version 14 (StataCorp, College Station, TX) using a two-sided 0.05 level of significance. We used linear regression models adjusted for baseline age, BMI, KL-scores, sex, and race to analyze the associations between presence of CaCs at baseline and changes in WORMS scores over four years, and to analyze the associations between total number of distinct circumscribed CaCs at baseline and changes in WORMS scores over four years (unit of increase for the predictor was +10 CaCs).

The variables baseline age, BMI, KL-scores, sex, and race were included for adjustment in the regression models, since these factors could be causal antecedents for OA and CaCs and therefore suspected confounders. Advanced radiographic OA is one of the strongest predictors of fast OA progression, with knees with higher KL-grades displaying greater rates of change in cartilage thickness than those with lower KL-grades [19]. Moreover, knees with higher KL-grades are more likely to have CaCs [10]. Obesity is considered the primary modifiable risk factor for knee OA [20] and patients with CaCs have been shown to have a higher average BMI compared to patients without chondrocalcinosis [21]. Age is another important risk factor for CaCs and OA, with the prevalence of OA increasing from 13.5% in adults of 25 years and older, to 33.5% in adults above 65 years [5, 22]. Moreover, race and sex have also been associated with radiographic worsening of knee OA and CaCs [10, 23].

To check if the underlying assumptions for linear regression models were fulfilled, we conducted the following tests: we tested for linearity by including a quadratic term in the regression model and found linear relationships for all features. We tested for normality by using a qnorm plot and found a normal distribution of the residuals for all features. We checked for homoscedasticity and outliers by analyzing the residual plot versus the predicted values. We also checked for absence of multicollinearity using variance inflation factor values and found all values ≤ 1.2.

Inter-/intrareader reproducibility

For CaC MRI gradings the inter- and intraobserver agreement were assessed using Bland-Altman analysis [24]. The MRIs of all subjects were evaluated by both radiologists for presence of CaCs and number of CaCs. For the intraobserver agreement, the evaluation of 70 subjects was repeated with 14 days in between readings. The Bland-Altman analysis showed no statistically significant bias for the interobserver agreement between both radiologists, nor between the intraobserver readings of each reader [10].

Intra-and interreader reproducibility of WORMS grading by our group have been validated in multiple previous studies [10, 2528]. In these studies, intraclass correlation coefficients were calculated in order to compare WORMS subscores for the meniscus and cartilage. Intraclass correlation coefficients for intrareader reproducibility ranged between 0.80 (0.69–0.95) [10] and 0.96 (0.94–0.97) [26] for the meniscus and between 0.81 (0.68–0.91) [10] and 0.99 (0.98–0.99) [26] for the cartilage. Interreader intraclass correlation coefficients ranged between 0.81 (0.76–0.88) [10] and 0.97 (0.95–0.98) [26] for the meniscus and between 0.79 (0.72–0.868) [27] and 0.97 (0.95–0.98) [26] for the cartilage.

Results

Subject characteristics

The baseline age range for our cohort of subjects with CaCs spanned 48–78 years (mean ± standard deviation (SD) = 66.86±7.2 years). The baseline BMI range for subjects with CaCs spanned 18.2–36.7 kg/m2 (mean ± SD = 27.60±3.9 kg/m2). The baseline age range for our control cohort spanned 48–79 years (mean ± SD = 66.97±7.8 years) and the baseline BMI spanned 19.9–36.4 kg/m2 (mean ± SD = 27.76±3.5 kg/m2). Moreover, both the CaC and control cohort had similar distributions for sex, KL-grades, and race. There were more females (39/70. 56%) than males (31/70, 44%) in the CaC cohort and most subjects had a baseline right knee KL-grade of 2 (50/70, 71%), followed by a KL-grade of 0 (12/70, 17%) and a KL-grade of 1 (8/70, 11%). Knee trauma during the observation period occurred 11 subjects, of these 6 were in the CaC cohort, 5 in the cohort without CaCs. Subject characteristics are also summarized in supplementary material Table 1.

MR imaging findings

We analyzed the associations between presence of CaCs at baseline and changes in WORMS over four years. Overall, changes in WORMS scores reflected increased knee joint degeneration in knees with CaCs compared to controls without CaCs (Table 1). Progression of cartilage lesions was found in more knees with CaCs (53/70; 76%) than in controls without CaCs (36/70; 51%). In knees with CaCs, cartilage lesions most frequently progressed in the PAT (n=33) and MF (n=24), in knees without CaCs cartilage lesions most frequently progressed in the PAT (n=17) and TRO (n=15). Development of a new full-thickness cartilage lesion was found in 34/70 (49%) CaC knees and 22/70 (31%) without CaCs. Compared to knees without CaCs, cartilage lesions increased statistically significantly more in the PAT (coefficient: 0.33; 95% confidence interval (CI): 0.04–0.63; p=0.024), the MF (coefficient: 0.51; 95% CI: 0.18–0.83; p=0.003) and the LT (coefficient: 0.36; 95% CI: 0.01–0.71; p=0.044) compartment in the knees with CaCs as shown in Fig. 3. Moreover, knees with CaCs showed statistically significantly more progression of medial and lateral meniscus lesions (coefficient: 0.38; 95% CI: 0.00–0.75; p=0.049 and coefficient: 0.72; 95% CI: 0.12–1.32; p=0.020, respectively). Subchondral cysts increased more in knees with CaCs compared to knees without CaCs (coefficient: 0.64; 95% CI: 0.19–1.10; p=0.006). BMEP, ligamentous changes and effusion did not progress more in those with CaCs compared to those without CaCs.

Table 1:

Association of presence or absence of calcium crystals at baseline and changes in WORMS scores over 4 years

Changes in WORMS scores over 4 years Subjects with calcium crystals a (n=70) Subjects without calcium crystals a (n=70) Coefficient (95% CI) p-value*b
Cartilage
 Cartilage sum score 0.54 (0.43–0.65) 0.26 (0.15–0.37) 0.28 (0.12–0.44) 0.001
 PAT 0.72 (0.52–0.93) 0.39 (0.18–0.59) 0.33 (0.04–0.63) 0.024
 TRO 0.40 (0.17–0.63) 0.35 (0.12–0.56) 0.06 (−0.27–0.38) 0.736
 MF 0.81 (0.58–1.04) 0.30 (0.07–0.53) 0.51 (0.18–0.83) 0.003
 LF 0.45 (0.26–0.63) 0.24 (0.05–0.43) 0.21 (−0.06–0.47) 0.124
 MT 0.31 (0.15–0.47) 0.11 (0.00–0.27) 0.20 (−0.02–0.42) 0.081
 LT 0.54 (0.29–0.79) 0.18 (0.00–0.43) 0.36 (0.01–0.71) 0.044
Meniscus
 Sum of bilateral meniscus lesions 0.30 (0.21–0.38) 0.11 (0.03–0.20) 0.18 (0.06–0.30) 0.003
 Sum of medial meniscus lesions 0.68 (0.42–0.95) 0.30 (0.39–0.57) 0.38 (0.00–0.75) 0.049
 Sum of lateral meniscus lesions 1.10 (0.67–1.52) 0.38 (0.00–0.80) 0.72 (0.12–1.32) 0.020
BMEP 0.13 (0.07–0.19) 0.10 (0.04–0.16) 0.03 (−0.06–0.11) 0.512
Subchondral cysts 0.63 (0.31–0.96) −0.01 (−0.33–0.31) 0.64 (0.19–1.10) 0.006
Ligaments 0.10 (−0.06–0.26) 0.02 (−0.13–0.19) 0.07 (−0.16–0.29) 0.564
Effusion 0.28 (0.13–0.43) 0.15 (0.00–0.29) 0.14 (−0.73–0.35) 0.201
*

Significant values are in bold

a

Numbers are given as adjusted means (95% CI)

b

Multivariable linear regression adjusting for age, sex, BMI, KL and race

Abbreviations: patella (PAT), trochlea (TRO), medial femur (MF), lateral femur (LF), medial tibia (MT), lateral tibia (LT)

Figure 3:

Figure 3:

Mean and standard error of change in WORMS cartilage score of the patella (PAT), medial femur (MF), and lateral tibia (LT) over 4 years in knees with and without calcium crystals. Knees with calcium crystals had statistically significantly more cartilage degeneration in the PAT, MF and LT compared to knees without calcium crystals.

We assessed the association of total number of distinct circumscribed CaCs at baseline and changes in WORMS over four years (Table 2). The cartilage compartment with the highest mean±SD number of CaCs at baseline was the PAT (9.4±11), followed by the LT (8.1±8.6), LF (6.4±9.0), MF (6.2±8.9), TRO (4.9±6.2), and MT compartment (0.8±1.9). Higher numbers of circumscribed CaCs at baseline was associated with increased morphological knee joint damage over four years. In the analysis of the subregions, knees with higher numbers of CaCs had increased cartilage degeneration in the PAT and the MF compartment (coefficient: 0.09; 95% CI: 0.05–0.14; p<0.001 and coefficient: 0.08; 95% CI: 0.02–0.14; p=0.005, unit of increase for predictor +10 CaCs) and statistically significantly more changes of the cartilage sum score (coefficient: 0.03; 95% CI: 0.01–0.06; p=0.016, unit of increase for predictor +10 CaCs) compared to knees with lower numbers of CaCs at baseline. Changes in meniscal lesions, BMEP, subchondral cysts, ligamentous changes, and effusion WORMS subscores over four years were not associated with number of baseline CaCs.

Table 2:

Association of total number of distinet circumscribed calcium crystals at baseline and changes in WORMS scores over 4 years.

Changes in WORMS scores over 4 years Coefficient (95% CI) p-value*a
Cartilage
 Cartilage sum score 0.03 (0.01–0.06) 0.016
 PAT 0.09 (0.05–0.14) <0.001
 TRO 0.00 (−0.06–0.05) 0.943
 MF 0.08 (0.02–0.14) 0.005
 LF 0.00 (−0.04–0.05) 0.868
 MT 0.01 (−0.03–0.05) 0.716
 LT 0.02 (−0.04–0.08) 0.492
Meniscus
 Sum of bilateral meniscus lesions 0.02 (0.00–0.04) 0.108
 Sum of medial meniscus lesions 0.02 (−0.04–0.09) 0.483
 Sum of lateral meniscus lesions 0.08 (−0.03–0.18) 0.136
Bone marrow edema pattern −0.01 (−0.02–0.01) 0.491
Subchondral cysts 0.05 (−0.03–0.13) 0.190
Ligaments 0.02 (−0.02–0.06) 0.329
Effusion 0.03 (−0.01–0.06) 0.167
*

Significant values are in bold

a

Multivariable linear regression adjusting for age, sex, BMI, KL and race. Unit of increase for the predictor is +10 calcium crystals

Abbreviations: patella (PAT), trochlea (TRO), medial femur (MF), lateral femur (LF), medial tibia (MT), lateral tibia (LT)

Discussion

In this longitudinal study we analyzed the association of CaCs and structural knee joint degeneration over four years, using 3T MRI to evaluate progression of cartilage lesions and damage to adjacent joint structures. We found that presence of CaCs was associated with increased knee joint degeneration compared to knees without CaCs. Cartilage compartments with statistically significantly increased degeneration included the PAT, the MF, and the LT compartment. Moreover, higher numbers of distinct circumscribed CaCs at baseline was associated with increased cartilage loss.

The pathophysiology of CaC depositions and the relationship to knee OA is unclear. CaCs have been shown to lower the synthesis of proteinase inhibitors such as tissue inhibitors of metalloproteinases causing increased tissue damage [29]. In addition, CaCs cause mechanical damage to joint structures by increasing the wear of the articular surface [29]. While synovitis is frequently associated with CaCs and is assumed to cause more damage to knee joint structures [30], a recent study found no difference in synovitis between subjects with radiographic chondrocalcinosis compared to controls without radiographic chondrocalcinosis [11]. These findings are in line with our results that showed no statistically significant differences between changes of effusion scores in knees with or without CaCs; though effusion is likely to fluctuate to show a steady increase.

To date, to the best of our knowledge, only two published studies have reported an association of CaCs and cartilage degeneration assessed using MRI [9, 10], and the results are different. Gersing et al reported that CaCs, confirmed on radiographs and MR images, are associated with a higher prevalence of cartilage and meniscal damage assessed using 3T MRI [10]. More previous to the mentioned study, Neogi et al found no association between presence of radiographic chondrocalcinosis and increased cartilage loss using 1.5T MRI [9]. We found that prevalent CaCs at baseline increased structural knee joint degeneration over four years, using 3T MR imaging to assess morphological changes. Moreover, our results indicate that presence of CaCs is also associated with increased damage of adjacent joint structures such as meniscal damage and subchondral cysts.

Interestingly, a higher total number of distinct circumscribed CaCs at baseline was associated with increased cartilage loss over four years, however no associations were found for BMEP, meniscal lesions, subchondral cysts, ligamentous changes and effusion WORMS subscores. These findings may have clinical implications since the total number of CaC depositions could be a useful measure to assess disease burden and risk of OA onset and worsening. Moreover, these results suggest a role for MR evaluation in subjects with chondrocalcinosis to assess both burden of CaCs and structural knee changes.

Our study has some limitations. Since no synovial fluid was available for analysis, the type of CaCs remained unknown. Therefore, we cannot differentiate between specific types of CaCs and differences regarding their association with OA onset and worsening. Moreover, while 3D TlwGE sequences have previously been correlated with CaC depositions radiographs, to the best of our knowledge to date no histopathological correlation has been performed of meniscal or cartilage tissue appearing as focal hypointense lesions on 3D TlwGE sequences. Therefore, it would be of interest to determine the differential diagnostic possibilities for focal hypointense lesions on gradient-echo sequences in the meniscus or cartilage. Our study was also limited by our sample size and the number of structural features we explored. Further research with a larger sample size of adults with chondrocalcinosis may help further refine our understanding of chondrocalcinosis and help develop a clinically useful predictive model. Despite these limitations, our study has a number of strengths including the use of state of the art 3T MR images to assess morphological changes and determining quantity of CaC depositions using gradient echo MRI sequences in addition to radiographs.

In conclusion, knees with CaCs have increased knee joint degeneration over four years compared to knees without CaCs. Cartilage compartments mainly affected by presence of CaCs were the PAT, the MF, and the LT compartment. Moreover, in knees with CaCs, a higher number of distinct circumscribed CaCs was associated with increased morphological knee joint degeneration suggesting that the number of CaC depositions could be a useful measure to assess disease burden and risk of OA onset and worsening.

Supplementary Material

1
2

Acknowledgments

We would like to thank the participants and staff of the Coordinating Center of the OAI for their invaluable assistance with patient selection, statistical analysis, and technical support.

Role of the funding source

The study was supported by the OAI, a public-private partnership comprising 5 NIH contracts (National Institute of Arthritis and Musculoskeletal and Skin Diseases contracts N01-AR-2–2258, N01-AR-2–2259, N01-AR-2–2260, N01-AR-2–2261, and N01-AR-2–2262), with research conducted by the OAI Study Investigators. The study was also funded in part by the Intramural Research Program of the National Institute on Aging, NIH. Private funding partners include Merck Research, Novartis Pharmaceuticals, GlaxoSmithKline, and Pfizer; the private sector funding for the OAI is managed by the Foundation for the National Institutes of Health. The analyses in this study were funded through the NIH/NIAMS (National Institute of Arthritis and Musculoskeletal and Skin Diseases grants R01AR064771 and P50-AR060752).

Footnotes

Competing interest statement

None of the authors have any financial or other interests related to the manuscript submitted to Osteoarthritis and Cartilage that might constitute a potential conflict of interest.

Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.

Contributor Information

Sarah C. Foreman, Department of Radiology and Biomedical Imaging, University of California, San Francisco; San Francisco, CA, USA; Department of Radiology, Technical University of Munich; Munich; Germany.

Alexandra S. Gersing, Department of Radiology, Technical University of Munich; Munich; Germany.

Claudio E. von Schacky, Department of Radiology and Biomedical Imaging, University of California, San Francisco; San Francisco, CA, USA.

Gabby B. Joseph, Department of Radiology and Biomedical Imaging, University of California, San Francisco; San Francisco, CA, USA.

Jan Neumann, Department of Radiology, Technical University of Munich; Munich; Germany.

Nancy E. Lane, Department of Medicine, University of California, Davis, CA, USA.

Charles E. McCulloch, Department of Epidemiology and Biostatistics, University of California, San Francisco; San Francisco, CA, USA.

Michael C. Nevitt, Department of Epidemiology and Biostatistics, University of California, San Francisco; San Francisco, CA, USA.

Thomas M. Link, Department of Radiology and Biomedical Imaging, University of California, San Francisco; San Francisco, CA, USA.

References

  • 1.Steinbach LS. Calcium pyrophosphate dihydrate and calcium hydroxyapatite crystal deposition diseases: imaging perspectives. Radiol Clin North Am 2004; 42: 185–205, vii. [DOI] [PubMed] [Google Scholar]
  • 2.Ea HK, Liote F. Advances in understanding calcium-containing crystal disease. Curr Opin Rheumatol 2009; 21: 150–157. [DOI] [PubMed] [Google Scholar]
  • 3.Wise CM. Crystal-associated arthritis in the elderly. Rheum Dis Clin North Am 2007; 33: 33–55. [DOI] [PubMed] [Google Scholar]
  • 4.Fuerst M, Bertrand J, Lammers L, Dreier R, Echtermeyer F, Nitschke Y, et al. Calcification of articular cartilage in human osteoarthritis. Arthritis Rheum 2009; 60: 2694–2703. [DOI] [PubMed] [Google Scholar]
  • 5.Mitsuyama H, Healey RM, Terkeltaub RA, Coutts RD, Amiel D. Calcification of human articular knee cartilage is primarily an effect of aging rather than osteoarthritis. Osteoarthritis Cartilage 2007; 15: 559–565. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Misra D, Guermazi A, Sieren JP, Lynch J, Torner J, Neogi T, et al. CT imaging for evaluation of calcium crystal deposition in the knee: initial experience from the Multicenter Osteoarthritis (MOST) study. Osteoarthritis Cartilage 2015; 23: 244–248. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Felson DT, Anderson JJ, Naimark A, Kannel W, Meenan RF. The prevalence of chondrocalcinosis in the elderly and its association with knee osteoarthritis: the Framingham Study. J Rheumatol 1989; 16: 1241–1245. [PubMed] [Google Scholar]
  • 8.Nowatzky J, Howard R, Pillinger MH, Krasnokutsky S. The role of uric acid and other crystals in osteoarthritis. Curr Rheumatol Rep 2010; 12: 142–148. [DOI] [PubMed] [Google Scholar]
  • 9.Neogi T, Nevitt M, Niu J, LaValley MP, Hunter DJ, Terkeltaub R, et al. Lack of association between chondrocalcinosis and increased risk of cartilage loss in knees with osteoarthritis: results of two prospective longitudinal magnetic resonance imaging studies. Arthritis Rheum 2006; 54: 1822–1828. [DOI] [PubMed] [Google Scholar]
  • 10.Gersing AS, Schwaiger BJ, Heilmeier U, Joseph GB, Facchetti L, Kretzschmar M, et al. Evaluation of Chondrocalcinosis and Associated Knee Joint Degeneration Using MR Imaging: Data from the Osteoarthritis Initiative. Eur Radiol 2017; 27: 2497–2506. [DOI] [PubMed] [Google Scholar]
  • 11.Han BK, Kim W, Niu J, Basnyat S, Barshay V, Gaughan JP, et al. Association of Chondrocalcinosis in Knee Joints With Pain and Synovitis: Data From the Osteoarthritis Initiative. Arthritis Care Res (Hoboken) 2017; 69: 1651–1658. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Peterfy CG, Schneider E, Nevitt M. The osteoarthritis initiative: report on the design rationale for the magnetic resonance imaging protocol for the knee. Osteoarthritis Cartilage 2008; 16: 1433–1441. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Riederer I, Karampinos DC, Settles M, Preibisch C, Bauer JS, Kleine JF, et al. Double inversion recovery sequence of the cervical spinal cord in multiple sclerosis and related inflammatory diseases. AJNR Am J Neuroradiol 2015; 36: 219–225. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Rauscher I, Stahl R, Cheng J, Li X, Huber MB, Luke A, et al. Meniscal measurements of T1rho and T2 at MR imaging in healthy subjects and patients with osteoarthritis. Radiology 2008; 249: 591–600. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Kaushik S, Erickson JK, Palmer WE, Winalski CS, Kilpatrick SJ, Weissman BN. Effect of chondrocalcinosis on the MR imaging of knee menisci. AJR Am J Roentgenol 2001; 177: 905–909. [DOI] [PubMed] [Google Scholar]
  • 16.Stehling C, Lane NE, Nevitt MC, Lynch J, McCulloch CE, Link TM. Subjects with higher physical activity levels have more severe focal knee lesions diagnosed with 3T MRI: analysis of a non-symptomatic cohort of the osteoarthritis initiative. Osteoarthritis Cartilage 2010; 18: 776–786. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Stehling C, Liebl H, Krug R, Lane NE, Nevitt MC, Lynch J, et al. Patellar cartilage: T2 values and morphologic abnormalities at 3.0-T MR imaging in relation to physical activity in asymptomatic subjects from the osteoarthritis initiative. Radiology 2010; 254: 509–520. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Kretzschmar M, Lin W, Nardo L, Joseph GB, Dunlop DD, Heilmeier U, et al. Association of Physical Activity Measured by Accelerometer, Knee Joint Abnormalities, and Cartilage T2 Measurements Obtained From 3T Magnetic Resonance Imaging: Data From the Osteoarthritis Initiative. Arthritis Care Res (Hoboken) 2015; 67: 1272–1280. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Buck RJ, Wirth W, Dreher D, Nevitt M, Eckstein F. Frequency and spatial distribution of cartilage thickness change in knee osteoarthritis and its relation to clinical and radiographic covariates - data from the osteoarthritis initiative. Osteoarthritis Cartilage 2013; 21: 102–109. [DOI] [PubMed] [Google Scholar]
  • 20.Zheng H, Chen C. Body mass index and risk of knee osteoarthritis: systematic review and meta-analysis of prospective studies. BMJ Open 2015; 5: e007568. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Karimzadeh H, Sirous M, Sadati SN, Bashshash M, Mottaghi P, Ommani B, et al. Prevalence of Chondrocalcinosis in Patients above 50 Years and the Relationship with Osteoarthritis. Adv Biomed Res 2017; 6: 98. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Lawrence RC, Felson DT, Helmick CG, Arnold LM, Choi H, Deyo RA, et al. Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part II. Arthritis Rheum 2008; 58: 26–35. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Vina ER, Ran D, Ashbeck EL, Ratzlaff C, Kwoh CK. Race, sex, and risk factors in radiographic worsening of knee osteoarthritis. Semin Arthritis Rheum 2018; 47: 464–471. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Correlation Bunce C., agreement, and Bland-Altman analysis: statistical analysis of method comparison studies. Am J Ophthalmol 2009; 148: 4–6. [DOI] [PubMed] [Google Scholar]
  • 25.Chanchek N, Gersing AS, Schwaiger BJ, Nevitt MC, Neumann J, Joseph GB, et al. Association of diabetes mellitus and biochemical knee cartilage composition assessed by T2 relaxation time measurements: Data from the osteoarthritis initiative. J Magn Reson Imaging 2017. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Neumann J, Guimaraes JB, Heilmeier U, Joseph GB, Nevitt MC, McCulloch CE, et al. Diabetics show accelerated progression of knee cartilage and meniscal lesions: data from the osteoarthritis initiative. Skeletal Radiol 2018. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Bucknor MD, Nardo L, Joseph GB, Alizai H, Srikhum W, Nevitt MC, et al. Association of cartilage degeneration with four year weight gain−−3T MRI data from the Osteoarthritis Initiative. Osteoarthritis Cartilage 2015; 23: 525–531. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Baum T, Joseph GB, Arulanandan A, Nardo L, Virayavanich W, Carballido-Gamio J, et al. Association of magnetic resonance imaging-based knee cartilage T2 measurements and focal knee lesions with knee pain: data from the Osteoarthritis Initiative. Arthritis Care Res (Hoboken) 2012; 64: 248–255. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Cheung HS. Calcium crystal effects on the cells of the joint: implications for pathogenesis of disease. Curr Opin Rheumatol 2000; 12: 223–227. [DOI] [PubMed] [Google Scholar]
  • 30.Landis RC, Haskard DO. Pathogenesis of crystal-induced inflammation. Curr Rheumatol Rep 2001; 3: 36–41. [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

1
2

RESOURCES